Menactra: Clinical Trials

3 trials of Menactra, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 31Completed 1

Follow Menactra: new trials by email Literature Review of Menactra trials Research Report on Menactra

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age
NmCV-5, Menactra - Vaccine for Meningococcal Disease
Phase 2 / Phase 3CompletedSerum Institute of India Pvt. Ltd.16402019-12-272021-09-08
Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali
Pfs230D1M-EPA/AS01, HAVRIX, TYPHIM Vi (Salmonella typhi vaccine) - Malaria
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)13012019-04-242024-10-22
Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds
Non-adjuvanted study formulation NmCV-5, Adjuvanted study formulation NmCV-5, Menactra - Meningitis, Meningococcal
Phase 2CompletedSerum Institute of India Pvt. Ltd.3752017-11-152025-05-25

Conditions studied

Malaria (1)  ·  Meningitis, Meningococcal (1)

Sponsors

Serum Institute of India Pvt. Ltd. (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

Mali (2)  ·  India (1)

Top investigators

Dr Prasad Kulkarni, MD (1)  ·  Patrick E Duffy, M.D. (1)

Results publications

PMID 34077644, PMID 39521012, PMID 39787798